Cigna said Tuesday that it is looking to terminate its merger agreement with Anthem, and seek a $1.85 billion break-up fee and additional damages exceeding $13 billion.
Cigna’s suit comes in the wake of a federal court’s decision blocking the planned $54 billion merger between the two insurers — a deal Cigna argues is effectively dead.
“In light of the Court’s ruling, Cigna believes that the transaction cannot and will not achieve regulatory approval and that terminating the agreement is in the best interest of Cigna’s shareholders,” the Connecticut-based insurer said in a statement.
Cigna added it filed its suit in the Delaware Court of Chancery to seek a judgment that it “has lawfully terminated the merger agreement and that Anthem is not permitted to extend the termination date.”
Anthem is the nation’s largest Blue Cross insurer, and Cigna claims that Anthem put the interests of the Blue Cross Blue Shield Association ahead of their deal, and as a result Cigna shareholders lost out during the prolonged merger process.
Anthem and Cigna’s relationship has been contentious for more than three years, since they began having merger discussions early in 2015. During their antitrust review, attorneys from the Department of Justice introduced correspondence between the insurers accusing one another of not living up to their merger agreement.
Full Content: Washington Post
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Mozilla CFO Warns Antitrust Remedies Could Doom Firefox
May 4, 2025 by
CPI
White & Case Strengthens Antitrust Practice in London with New Partner Appointment
May 4, 2025 by
CPI
Upstate New York Health Provider Asks Appeals Court to Revive Insulin Price-Fixing Suit
May 4, 2025 by
CPI
Judicial Panel Advances Rule to Scrutinize AI-Generated Evidence
May 4, 2025 by
CPI
EU Antitrust Ruling on UniCredit’s Banco BPM Takeover Expected by Early June
May 4, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Mergers in Digital Markets
Apr 21, 2025 by
CPI
Catching a Killer? Six “Genetic Markers” to Assess Nascent Competitor Acquisitions
Apr 21, 2025 by
John Taladay & Christine Ryu-Naya
Digital Decoded: Is There More Scope for Digital Mergers In 2025?
Apr 21, 2025 by
Colin Raftery, Michele Davis, Sarah Jensen & Martin Dickson
AI In the Mix – An Ever-Evolving Approach to Jurisdiction Over Digital Mergers in Europe
Apr 21, 2025 by
Ingrid Vandenborre & Ketevan Zukakishvili
Antitrust Enforcement Errors Due to a Failure to Understand Organizational Capabilities and Dynamic Competition
Apr 21, 2025 by
Magdalena Kuyterink & David J. Teece